ECS Botanics Holdings Ltd

CHIA:ECS Stock Report

Market Cap: AU$18.0m

ECS Botanics Holdings Management

Management criteria checks 2/4

ECS Botanics Holdings' CEO is Nan-Maree Schoerie, appointed in Jun 2022, has a tenure of 2.67 years. total yearly compensation is A$520.84K, comprised of 60.9% salary and 39.1% bonuses, including company stock and options. directly owns 9.33% of the company’s shares, worth A$1.68M. The average tenure of the management team and the board of directors is 3.1 years and 0.3 years respectively.

Key information

Nan-Maree Schoerie

Chief executive officer

AU$520.8k

Total compensation

CEO salary percentage60.9%
CEO tenure2.7yrs
CEO ownership9.3%
Management average tenure3.1yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nan-Maree Schoerie's remuneration changed compared to ECS Botanics Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$521kAU$317k

AU$2m

Mar 31 2024n/an/a

AU$2m

Dec 31 2023n/an/a

AU$2m

Sep 30 2023n/an/a

AU$1m

Jun 30 2023AU$323kAU$227k

AU$491k

Dec 31 2022n/an/a

AU$2m

Sep 30 2022n/an/a

AU$1m

Jun 30 2022AU$188kAU$178k

AU$166k

Mar 31 2022n/an/a

-AU$3m

Dec 31 2021n/an/a

-AU$4m

Sep 30 2021n/an/a

-AU$4m

Jun 30 2021AU$162kAU$47k

-AU$4m

Compensation vs Market: Nan-Maree's total compensation ($USD323.66K) is about average for companies of similar size in the Australian market ($USD283.93K).

Compensation vs Earnings: Nan-Maree's compensation has increased by more than 20% in the past year.

CEO

Nan-Maree Schoerie

2.7yrs

Tenure

AU$520,836

Compensation

Ms. Nan-Maree Schoerie, Dip Chem has been Executive Director at ECS Botanics Holdings Ltd since March 15, 2021 and also its Managing Director from June 14, 2022. She is Executive General Manager of medicin...

Leadership Team

NamePositionTenureCompensationOwnership
Nan-Maree Schoerie
MD & Executive Director2.7yrsAU$520.84k9.33%
A$ 1.7m
Arthur Sun
Chief Financial Officerno dataAU$262.26kno data
Nicholas Thomas
Chief Operating Officerless than a yearno datano data
Michael Clark
Head of European Operations3.5yrsno datano data
Mauro Piccini
Company Secretary7.3yrsno datano data

3.1yrs

Average Tenure

Experienced Management: ECS's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nan-Maree Schoerie
MD & Executive Director3.9yrsAU$520.84k9.33%
A$ 1.7m
Jeremy King
Non-Executive Chairman8.1yrsAU$86.55k0.47%
A$ 85.4k
Michael Nitsche
Non-Executive Director5.9yrsAU$39.96kno data
Rachel Swift
Non-Executive Directorless than a yearno datano data
Natasha Feingold
Member of Medical Advisory Boardless than a yearno datano data
Rupert Backhouse
Member of Medical Advisory Boardless than a yearno datano data
Charlotte Middleton
Member of Medical Advisory Boardless than a yearno datano data
Phil Burrell
Member of Medical Advisory Boardless than a yearno datano data
Jane Chapman
Member of Medical Advisory Boardless than a yearno datano data
Christopher Schneider
Member of Medical Advisory Boardless than a yearno datano data
Justin Welsh
Member of Medical Advisory Boardless than a yearno datano data

0.3yrs

Average Tenure

Experienced Board: ECS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 03:43
End of Day Share Price 2025/01/31 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ECS Botanics Holdings Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stuart RobertsPitt Street Research Pty Ltd.